Insmed reported $375.99M in Loan Capital for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Acelrx Pharmaceuticals ACRX:US $ 11.26M 1.88M
Alimera Sciences ALIM:US $ 42.8M 0.12M
Arena Pharmaceuticals ARNA:US $ 40.03M 1.18M
Biomarin Pharmaceutical BMRN:US $ 1076.13M 3.02M
Cytokinetics CYTK:US $ 131.76M 3.95M
Dynavax Technologies DVAX:US $ 179.89M 0.08M
Flexion Therapeutics FLXN:US $ 205.03M 1.87M
Insmed INSM:US $ 375.99M 4.96M
Mirati Therapeutics MRTX:US $ 0M 0M
Novartis NVS:US $ 26491M 908M
Regeneron Pharmaceuticals REGN:US $ 1978.9M 716.8M
Sarepta Therapeutics SRPT:US $ 1091.11M 98.62M
Seattle Genetics SGEN:US $ 0M 0M
Ultragenyx Pharmaceutical RARE:US $ 0M 0.7M
Vertex Pharmaceuticals VRTX:US $ 572.86M 33.81M